Startseite

Tioconazole

Tioconazole

Spezifikationen

65899-73-2CAS-Nummer
265-973-8EG-Nummer
1-[2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazoleIUPAC-Name
C16H13Cl3N2OSChemische Formel
387.7 g/molMolekulargewicht
tioconazole; 65899-73-2; Vagistat; Vagistat-1; Trosyd; Trosyl; Tioconazol; Tioconazolum; UK-20349; 1-(2-((2-chlorothiophen-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole; (+-)-Tioconazole; DTXSID3046619; UK 20349; UK-20,349; NSC-759169; S57Y5X1117; (+-)-1-(2,4-Dichloro-beta-((2-chloro-3-ethenyl)oxy)phenethyl)imidazole; DTXCID1026619; 1H-Imidazole, 1-(2-((2-chloro-3-thienyl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-; 1-{2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole; trosid; tioconazolo; Trosderm; Tioconazole 1; Leader Ticonazole; 1H-Imidazole, 1-[2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-; Tioconazole 1 Day; Leader Tioconazole 1; basic care tioconazole; Sunmark Tioconazole 1; Topcare Tioconazole 1; CareOne Tioconazole 1; Equaline Tioconazole 1; dg health tioconazole 1; RefChem:56489; good sense tioconazole 1; Equate Tioconazole 1 Day; Up and Up Tioconazole 1; Tioconazole Ointment 6.5%; foster and thrive tioconazole; Signature Care Tioconazole 1; MONISTAT TIOCONAZOLE 1; CHEBI:9604; Tioconazole 1 1 Dose Treatment; D01AC07; G01AF08; 265-973-8; Gyno-trosyd; Fungibacid; Zoniden; Tioconazol [INN-Spanish]; Tioconazolum [INN-Latin]; 1-[2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole; MFCD00057276; 1-[(2S)-2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole; NCGC00167430-01; Tz-3; C16H13Cl3N2OS; 1-[2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole; New Straitus; 1-{2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole; SMR001550005; CAS-65899-73-2; Vagistat-1 (TN); SR-05000001939; EINECS 265-973-8; BRN 0573867; Tioconazole (JAN/USP/INN); UNII-S57Y5X1117; 1-(2,4-Dichloro-beta-((2-chloro-3-thenyl)-oxy)phenethyl)imidazole; Tioconazole; 1-[(2RS)-2-[(2-Chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole; Tioconazole, 97%; Tioconazole [USAN:USP:INN:BAN:JAN]; Tioconazole (Standard); TIOCONAZOLE [MI]; 1-(2,4-Dichloro-(beta-(2-chloro-3-thenyl)oxy)phenethyl)imidazole; TIOCONAZOLE [INN]; TIOCONAZOLE [JAN]; (.+/-.)-Tioconazole; TIOCONAZOLE [USAN]; TIOCONAZOLE [VANDF]; TIOCONAZOLE [MART.]; SCHEMBL41354; TIOCONAZOLE [USP-RS]; TIOCONAZOLE [WHO-DD]; 5-23-04-00324 (Beilstein Handbook Reference); MLS003899209; MLS004712040; MLS006010907; orb1224316; orb1310895; CHEMBL1200438; SCHEMBL29408808; CHEBI:77898; GTPL13859; HY-B0319R; TIOCONAZOLE [ORANGE BOOK]; HMS2090B12; HMS2093P11; HMS3655K22; HMS3712I10; HMS5080L03; Pharmakon1600-01505581; TIOCONAZOLE [EP MONOGRAPH]; TIOCONAZOLE [USP IMPURITY]; TIOCONAZOLE [USP MONOGRAPH]; HY-B0319; QCA89973; Tox21_112434; BDBM50370218; DL-515; EBC-03904; NSC759169; s1910; AKOS015906500; Tioconazole for system suitability CRS; Tox21_112434_1; CCG-213487; DB01007; KS-5114; NSC 759169; (+-)-1-[2-[(2-Chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole; NCGC00167430-02; NCGC00167430-03; NCGC00167430-04; NCGC00167430-11; AC-13425; AC-31721; SBI-0206824.P001; NS00010049; SW198590-2; C08082; D00890; D83125; AB01275523-01; AB01275523_02; AB01275523_03; Tioconazole, VETRANAL(TM), analytical standard; F811938; Q260326; SR-05000001939-1; SR-05000001939-2; BRD-A33084557-001-01-7; BRD-A33084557-001-06-6; BRD-A33084557-001-07-4; Z2520891696; Tioconazole, United States Pharmacopeia (USP) Reference Standard; 1-[2,4-Dichloro-.beta.-[(2-chloro-3-thenyl)-oxy]phenethyl]imidazole; (.+/-.)-1-(2,4-Dichloro-.beta.-((2-chloro-3-ethenyl)oxy)phenethyl)imidazole; 1-[(2RS)-2-[(2-Chlorothiophen-3-yl)methoxy]-2-(2,4- dichlorophenyl)ethyl]-1H-imidazole; 1-[2-[(2-Chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole #; 1-{2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole; Tioconazole for system suitability, European Pharmacopoeia (EP) Reference StandardSynonyme